Totus Medicines Inc.
Industry
- Pharmaceuticals
- Biotechnology
- Drug Discovery Technologies
See more in Biomedtracker
Latest on Totus Medicines Inc.
Scrip
• By Joseph Haas, Vibha Ravi, and Dexter Jie Yan
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Merck KGaA Pays $600m For Transfection
Scrip
• By Mandy Jackson
The end of 2023 is proving no different from the end of any other year, with venture capital firms and biopharmaceutical companies closing out a flurry of new VC funds and financings before December d
Scrip
• By Joseph Haas
Lysogene Licenses Gene Therapy Candidate From Yeda Research Advancing a collaboration inked in July 2020, gene therapy specialist Lysogene SA said on 12 April that it is taking its option to license